Glenmark launches Rufinamide Tablets USP, 200 mg and 400 mg
It is indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) along with other medicines
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Four pharma firms get approval under PLI scheme for bulk drugs
Solara Active Pharma Science, Rajasthan Antibiotics, Dhatri Lab and Vital Laboratories received approval
Generic Pharmasec signs distribution and marketing pact with Abbott Point of Care
Aim to increase i-STAT devices penetration by at least 1,000 additional hospital set-ups in the next 24 months by creating…
JB Chemicals launches medicated nicotine lozenges and AI-enabled Chatbot to help quit smoking
NOSMOK prescription medicated nicotine lozenges will be available as 2mg and 4mg lozenges in sugar-free and sugar-based variants…
Modern Laboratories to produce Amphotericin B to treat black fungus
The price in the market will be around Rs 3,000, while we will give the government around Rs 1,500, said Anil Kharia, Chairman,…
Zydus Cadila gets USFDA approval for Fluphenazine Hydrochloride Tablets
This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia)
Neuropathic pain market to reach $25.2 billon by 2027: GlobalData
There are currently 315 pain therapeutics in development globally
Astrazeneca gives rights to trademark for three diabetes drug brands to Sun Pharma
Consequently, AstraZeneca India and Sun Pharma have discontinued their existing distribution services agreement signed in 2016,…
RDIF, UNICEF sign agreement for supply of 220 million doses of Sputnik V vaccine
Concurrently, RDIF will be holding a separate discussion with Gavi, the Vaccine Alliance to see the Sputnik V vaccine considered…
Strides, TLC collaborate to launch black fungus drug in India
The CDSCO has approved TLC's new drug application (NDA) of Amphotericin B Liposome for Injection 50 mg in India for immediate…
BDR Pharma launches generic Rucaparib to treat advanced ovarian and prostate cancers
Rucaparib is launched under the brand name BDPARIB in two strengths of 200 mg and 300 mg
Lupin announces achievement of key milestones for its clinical stage MEK inhibitor compound
Lupin’s MEK inhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s KRAS inhibitor…
Tessol launches cold solutions for vaccine delivery
The startup has attained success in other industries where maintaining a cold chain during logistics is critical
Bio/pharma industry strives to solve shortage of viral vector used in many COVID-19 vaccines:…
Viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the…
Bal Pharma launches BALflu (favipiravir) tablets in India
This formulation is available with 400 mg strength at a price of Rs 85 per tablet
Vivimed exports its first shipment, Famotidine tablets, to Canada
Famotidine tablets are histamine H2 receptor antagonists used for the treatment of hyperacidity or acid indigestion
Cipla to market Roche’s antibody cocktail pan-India, first batch currently available
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in…
Glenmark gets US FDA nod for Icatibant injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled…
This marks Glenmark’s first synthetic decapeptide injectable approval and will be manufactured in their North American…
Zydus launches Ujvira (trastuzumab emtansine) for breast cancer treatment
The drug is being offered at Rs 32495 for a 100 mg vial
MSN Laboratories launches Posaconazole to treat mucormycosis
MSN has launched the product under the brand name PosaOne as 100 mg Delayed-Release tablets and 300 mg injections, respectively